Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

COVID-19 Update re: Noteholder Consent Request

11 Nov 2020 08:10

RNS Number : 9658E
Marston's PLC
11 November 2020
 

 

 

11 November 2020

MARSTON'S PLC

("Marston's" or "the Group")

 

COVID-19 Update re: Noteholder Consent Request

 

As previously announced in May this year, the Group received overwhelming support from its bondholders for certain waivers and amendments for 2020 within its Secured Estate, due to the Government's mandate to temporarily close pubs and restaurants across the UK from 20 March to 4 July 2020 in response to the COVID-19 pandemic.

As we guided in our trading update on 15 October, Marston's outperformed the market in the 13 weeks to 3 October. The Group was able to successfully reopen approximately 99% of its pubs, albeit under varying degrees of trading restrictions. Encouragingly, like for like sales at the Group's managed and franchised pubs were 90% of the previous financial year during the corresponding period and during August, like for like sales increased 6%, illustrating the Group's ability to reopen and trade its pubs well in spite of the continued restrictions imposed on the hospitality sector. Cash generation was also ahead of expectations.

Marston's announces today that it has formally asked the holders of its Secured Class A Notes for a limited number of further technical waivers during the first half of 2021, as a precautionary measure following the renewed lockdown restrictions introduced in Wales on 23 October, and in England last week. The waivers being requested are required solely as a consequence of the enforced temporary re-closure of its pubs in England by the UK Government as a result of the COVID--19 pandemic measures, together with the continued uncertainty with regard to further potential lockdowns over the winter months. Noteholders have been asked to respond by 1 December and a meeting is scheduled for 3 December 2020.

The financial and liquidity position of Marston's and its subsidiaries remains strong. As previously announced, the Group did not need to utilise the additional £70 million bank facility secured in May. In addition, the sale of Marston's Beer company to the joint venture with Carlsberg UK Holdings Limited completed in October, generating initial net proceeds of around £230 million, further reducing the Group's bank debt.

However, given the prevailing uncertain outlook, management are continuing to take a prudent approach and therefore believe it is appropriate to seek the waivers requested to provide the Security Group with maximum flexibility over the coming months should that be required.

In addition, and as previously announced, to further ensure that liquidity is maximised within the Security Group, it has agreed not to make any distributions to the wider Marston's Group until after 2 October 2021 at the earliest.

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2010/2005

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood

 

NOTES TO EDITORS

· Marston's is a leading pub operator with a 40% holding in Carlsberg Marston's Beer Company

· It has an estate of 1,379 pubs situated nationally, comprising managed, franchised and leased pubs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPFFFENEFEA
Date   Source Headline
1st Oct 20183:21 pmRNSTotal Voting Rights
21st Sep 20183:04 pmRNSHolding(s) in Company
20th Sep 201810:21 amRNSHolding(s) in Company
19th Sep 20188:12 amRNSDirector Declaration
17th Sep 20189:57 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSAppointment of Chairman
5th Sep 20182:00 pmRNSHolding(s) in Company
21st Aug 20189:07 amRNSHolding(s) in Company
14th Aug 20189:29 amRNSHolding(s) in Company
7th Aug 201812:23 pmRNSDirector/PDMR Shareholding
2nd Aug 20188:46 amRNSDirector Declaration
31st Jul 20187:30 amRNSDirector Declaration
25th Jul 20182:15 pmRNSDirector Declaration
25th Jul 20187:00 amRNSTrading Update
19th Jul 20188:47 amRNSDirector Declaration
10th Jul 20181:38 pmRNSBlock listing Interim Review
3rd Jul 20182:19 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.